Table 5.

Percentage of 3-year survival in randomized trials in comparison to the present study

Study	N patients	IB2%	IIB%	IIIB%	IVA%	OS
GOG123	183	100	0	0	0	83
GOG85	177	0	61	33.9	2.8	67
RTOG9001	195	32	36	27	3	75
GOG120	177/173	0	51.8	42.4	2.6	65
THIS	294	23.2*	53.2	20.4**	0.7	76.5

*23.2% includes IB bulky and IIA; **20.4% includes 2.3% cases of IIIA. GOG85 and GOG120 had highest proportions of IIB and IIIB.